首页 | 本学科首页   官方微博 | 高级检索  
     

调节性T细胞与炎性肠病研究进展
引用本文:董云霞,孙蓬然,郑长青. 调节性T细胞与炎性肠病研究进展[J]. 实用药物与临床, 2007, 10(6): 361-364
作者姓名:董云霞  孙蓬然  郑长青
作者单位:中国医科大学八十九期七年制,沈阳,110001;中国医科大学附属盛京医院消化内科,沈阳,110004
摘    要:炎性肠病(Inflammatory bowel disease,IBD)为非特异性炎症性肠病,主要包括溃疡性结肠炎(Ul-cerative colitis,UC)和克罗恩病(Crohn’s disease,CD)。其病因和发病机制尚未完全明确。已知肠道粘膜免疫系统异常反应所导致的炎症反应在IBD中发挥着重要作用。笔者对调节性T细胞在肠道免疫系统中的作用与IBD的发病机制相关性的研究进展做一综述,为临床治疗IBD的新药研究提供可能性的途径。

关 键 词:炎性肠病  调节性T细胞  免疫抑制
收稿时间:2007-05-21
修稿时间:2007-05-21

Research progress of inflammatory bowel disease and the regulatory T cells
DONG Yun-xia,SUN Peng-ran,ZHENG Chang-qing. Research progress of inflammatory bowel disease and the regulatory T cells[J]. Practical Pharmacy and Clinical Remedies, 2007, 10(6): 361-364
Authors:DONG Yun-xia  SUN Peng-ran  ZHENG Chang-qing
Abstract:Inflammatory bowel disease(IBD),mainly including Ulcerative colitis(UC) and Crohn's disease(CD),is a kind of disease characterized by non-specific inflammatory reactions of the bowel.The etiology and pathogenes of it are unknown,though many experiments have shown an important role of abnormal immunal reaction of the intestinal mucosa in IBD.The authors evaluated the effect of regulatory T cells on the intestinal immune system,the pathogenesis of IBD,and the relation of them.
Keywords:Inflammatory bowel disease  Regulatory T cell  Immune inhibition
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号